$IBEX

Greenwald Taylor C sold $31K of IBEX

Greenwald Taylor C (Chief Financial Officer) sold 964 shares of IBEX Ltd (IBEX) at $32.02 on 2026-05-22.

Original reporting
SEC EDGAR · Greenwald Taylor C
Published May 27, 2026, 9:31 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI May 27, 2026, 9:35 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$IBEX
Neutral
medium confidence
Mentioned
$IBEX
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$IBEXNeutralLow
01

Why it matters

Insider selling can affect short-term sentiment, especially when not tied to a pre-arranged 10b5-1 plan, but there is no accompanying company-specific operational news.

02

Market read

Traders may monitor for follow-on selling or unusual insider activity, but this single Form 4 is unlikely to drive a sustained repricing without additional fundamentals.

03

What to watch

The filing does not state reasons for selling, and the share count/value ($30.9K) is relatively small versus typical institutional flows, limiting signal strength.

Relevance 6/10Timing: Immediate (filed May 27; sale executed May 22) but event is informational rather than catalytic.

Background

The article is an SEC Form 4 insider transaction disclosure for IBEX Ltd, reporting an officer/direct sale.

Company-level read

Ticker impact

$IBEXNeutralMedium confidence
Context

IBEX CFO Greenwald Taylor C filed an open-market sale of 964 shares on May 22, reducing direct holdings to 62,230.

Expected impact

Likely limited near-term impact; any move would be modest and sentiment-driven rather than thesis-changing.

Evidence & confidence

Form 4 insider sales are common and the filing provides no earnings/contract/litigation/drug-trial update; absence of a 10b5-1 plan can increase scrutiny but does not confirm negative fundamentals.

Market effects

Minimal; insider sale does not imply sector-wide change.

None indicated by the filing details.

None indicated.

Counterpoint

The sale could be routine liquidity/portfolio rebalancing; insider transactions often do not predict near-term performance.

Key entities

  • IBEX Ltd

    Subject of the SEC Form 4 insider transaction; CFO sold 964 shares on May 22.

  • Greenwald Taylor C

    IBEX CFO who executed the open-market sale; holdings after sale were 62,230 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$IBEXHigh

IBEX Ltd (IBEX): Results of Operations and Financial Condition

IBEX Ltd (IBEX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 IBEX Reports Record Fiscal Year 2026 Financial Results, Introduces Fiscal Year 2027 Guidance • Record fourth quarter revenue grew 12% versus prior year quarter, sixth consecutive quarter of double-digit growth • Nine new logo wins in the fourth quarter, including two